Beschreibung
Key Questions 1. For outpatients with depressive, anxiety, and/or premenstrual dysphoric disorders, do second-generation antidepressants differ in efficacy or effectiveness? 2. For outpatients with depressive, anxiety, and/or premenstrual dysphoric disorders, do second-generation antidepressants differ in harms or adverse events? 3. Are there subgroups of patients based on demographics (age, racial groups, socio-demographic factors, and sex), other medications, or comorbidities for which one second-generation antidepressant is more effective or associated with fewer adverse events than another?
Details
Projektzeitraum | 01.07.2009 - 31.03.2011 |
---|---|
Fördergeber | Sonstige |
Department | |
Projektverantwortung (Universität für Weiterbildung Krems) | Univ.-Prof. Dr. Gerald Gartlehner, MPH |
Projektmitarbeit |
Dr. Angela Kaminski-Hartenthaler
Michaela Strobelberger, MA
Dipl.-Ing. Patricia Tüchler
|